3 Pipeline Stocks With Sky-High Yields to Buy Now and Never Sell

Enterprise Products Partners offers a 6.0% yield and has raised its distribution for 27 consecutive years, while Energy Transfer yields 7.1% and targets 3% to 5% annual payout growth. MPLX has the highest yield in the group at 7.7% and has grown its distribution at an 11.6% compound annual rate since 2022. The article is broadly positive on the trio’s cash flow, leverage, and project pipelines, but it is mainly an income-stock recommendation rather than new material company-specific news.

Analysis

The immediate market implication is not that these names are “safe income,” but that the midstream sector is quietly becoming a self-funded capital return machine. The second-order effect is that persistent payout growth combined with retained cash should keep compressing implied equity risk premiums, especially for the highest-quality balance sheets; that favors names that can fund expansion without relying on equity issuance, and it likely starves weaker, more levered peers of capital over the next 12-24 months.

Among the three, the key differentiator is not yield but reinvestment optionality. EPD’s balance-sheet edge plus visible project backlog makes it the cleanest compounding story, while MPLX looks best positioned for near-term distribution growth because its coverage and leverage leave room for both buybacks/acquisitions and payout increases. ET still has the highest “reset risk” from its history of cutting, so the market may cap its multiple until it demonstrates several more quarters of uninterrupted increases; that creates a valuation asymmetry where good execution could re-rate the stock, but any stumble would be punished faster than the others.

A contrarian read: the consensus is likely underestimating how much of this story is already in the cash-flow math and overestimating the durability of headline yields if rates stay elevated. If Treasury yields remain sticky, these stocks may behave less like bond substitutes and more like leveraged cash-flow equities, meaning downside in a risk-off tape could be sharper than income buyers expect. The catalyst path is therefore quarters, not days: distribution hikes, coverage ratios, and project start-ups should matter more than commodity prices, which are only a secondary driver here.

The better trade is probably relative value rather than outright yield chasing. The strongest long is the name with the best combination of coverage, leverage, and visible growth, while the weakest is the one with the most reputational overhang from a prior cut; options can be useful because the event risk is dispersed over several quarterly updates rather than a single binary catalyst.

Key Decisions for Investors

• Long MPLX vs. ET on a 6-12 month horizon: MPLX has the cleaner balance-sheet/coverage profile, while ET carries a persistent trust discount from its prior cut; target re-rating if ET executes but expect MPLX to compound more reliably.
• Overweight EPD in income sleeves for 12-24 months: best risk/reward is not the highest yield but the most durable coverage plus backlog visibility; use pullbacks to add rather than chasing yield strength.
• Sell cash-secured puts on ET 3-6 months out if you want exposure with downside buffer: premium should compensate for the market's skepticism, and the trade benefits if the next few distribution hikes land without interruption.
• Pair trade long EPD / short a higher-beta midstream peer basket for 6-12 months: thesis is that capital will continue migrating toward self-funding operators with visible project pipelines and away from names that still need the market’s benefit of the doubt.
• If rates stay elevated, trim any oversized allocation after a 15-20% run: these names can de-rate quickly in a risk-off tape, so harvest gains and let the cash yield do the work rather than relying on multiple expansion.